BioLexis Pte Ltd.
SEC CIK 1716335 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| OTLK | Outlook Therapeutics, Inc. | 10% | 22.98M | — | — | 1 | 2022-04-21 | 2022-04-21 |
Most active insiders at OTLK, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Sukhtian Ghiath M. | Dir, 10% | $7.50M | — |
| 2 | HILZINGER KURT J | Dir | $176.5K | — |
| 3 | Sukhtian Faisal Ghiath | Dir | $150.0K | — |
| 4 | Haddadin Yezan Munther | Dir | $39.1K | — |
| 5 | THURMAN RANDY H | Dir | $2,145 | — |
| 6 | Jahr Robert Charles | CEO, Dir | — | — |
| 7 | KENYON LAWRENCE A | CFO, Dir | — | — |
BioLexis Pte Ltd. made no open-market trades at OTLK in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-04-22 | 2022-04-21 | OTLK | Outlook Therapeutics, Inc. | BioLexis Pte Ltd. | 10% | J - Other | — | -27.98M | 22.98M | -55% | — |
Purchase Sale Sale after option exercise All abbreviations